Skip to main content
. Author manuscript; available in PMC: 2016 Dec 27.
Published in final edited form as: Am J Prev Med. 2015 Dec 15;50(6):692–698. doi: 10.1016/j.amepre.2015.11.009

Table 2.

Antibiotic Prescription Among Outpatient Encounters with Infection Diagnosis, NAMCS 2006–2010

Characteristic Encounters for any infection (n=8,307) Encounters for respiratory infections (n=4,975)
Rates, % AOR (95% CI) Rates, % AOR (95% CI)
All 49.9 51.4
Tobacco use status
 No 48.7 ref 49.8 ref
 Yes 55.2 1.20 (1.02, 1.42) 57.8 1.31 (1.05, 1.62)
Gender
 Male 51.2 ref 52.9 ref
 Female 48.9 0.92 (0.81, 1.05) 50.7 0.98 (0.84, 1.14)
Race
 White 51.1 ref 52.1 ref
 Black 45.2 0.81 (0.66, 0.99) 49.8 1.00 (0.75, 1.32)
 Other 38.8 0.56 (0.38, 0.82) 41.1 0.60 (0.39, 0.93)
Age (years)
 18–24 53.4 ref 51.7 ref
 25–44 54.2 1.02 (0.80, 1.30) 56.4 1.16 (0.86, 1.56)
 45–64 50.8 0.84 (0.67, 1.06) 52.7 0.97 (0.73, 1.29)
 ≥65 41.6 0.59 (0.46, 0.77) 42.2 0.67 (0.48, 0.92)
Source of payment
 Private/other 53.0 ref 54.9 ref
 Medicaid 40.9 0.61 (0.47, 0.79) 39.0 0.54 (0.39, 0.77)
 Self-pay 46.4 1.00 (0.85, 1.17) 47.8 0.99 (0.80, 1.23)
Primary care physician
 No 42.2 ref 43.7 ref
 Yes 54.6 1.64 (1.39, 1.94) 55.1 1.50 (1.21, 1.88)
Comorbid conditions
 Asthma
 No 54.8 ref 60.3 ref
 Yes 29.5 0.35 (0.30, 0.42) 27.2 0.26 (0.21, 0.33)
Cancer
 No 50.3 ref 51.7 ref
 Yes 39.4 0.73 (0.52, 1.04) 39.2 0.70 (0.42, 1.16)
COPD
 No 49.5 ref 50.9 ref
 Yes 52.5 1.24 (1.04, 1.47) 53.6 1.13 (0.93, 1.39)
Diabetes
 No 50.4 ref 51.7 ref
 Yes 45.5 0.89 (0.71, 1.12) 49.2 0.97 (0.72, 1.29)

Note: Boldface indicates statistical significance (p<0.05).

COPD, chronic obstructive pulmonary disease; NAMCS, National Ambulatory Medical Care Survey.